Anavex Life Sciences Corp. (AVXL)
4.085
-0.32
(-7.37%)
USD |
NASDAQ |
Dec 10, 16:00
4.085
0.00 (0.00%)
After-Hours: 16:52
Anavex Life Sciences Total Assets (Quarterly): 103.82M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 601.14M |
| ADMA Biologics, Inc. | 568.69M |
| Aldeyra Therapeutics, Inc. | 77.80M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| CorMedix, Inc. | 750.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.946M |
| Shareholders Equity (Quarterly) | 94.87M |
| Current Ratio | 11.60 |